Skip to content
10-Q

Quarterly Report

PHARMOS CORP

0001513160-11-000064

← back to feed
Filed
Oct 31, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 31, 2011 59.88M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $693.18K
Stockholders Equity Q3 2011 · Dec 31, 2010 $2.02M
Current Liabilities Q3 2011 · Sep 30, 2011 $163.53K
Current Liabilities Q3 2011 · Dec 31, 2010 $171.11K
Total Liabilities Q3 2011 · Sep 30, 2011 $1.16M
Total Liabilities Q3 2011 · Dec 31, 2010 $1.17M
Current Assets Q3 2011 · Sep 30, 2011 $1.85M
Current Assets Q3 2011 · Dec 31, 2010 $3.19M
Total Assets Q3 2011 · Sep 30, 2011 $1.86M
Total Assets Q3 2011 · Dec 31, 2010 $3.19M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$1.41M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $3.22M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $4.63M
Sga Expense Q3 2011 · Sep 30, 2010 $295.94K
Sga Expense Q3 2011 · Sep 30, 2010 $935.74K
Rd Expense Q3 2011 · Sep 30, 2010 $153.81K
Rd Expense Q3 2011 · Sep 30, 2010 $380.16K
Net Income Q3 2011 · Sep 30, 2010 −$470.3K
Net Income Q3 2011 · Sep 30, 2010 −$1.39M
Operating Income Q3 2011 · Sep 30, 2010 −$450.11K
Operating Income Q3 2011 · Sep 30, 2010 −$1.32M